Literature DB >> 18840523

Unphosphorylated STATs go nuclear.

Stephen Brown1, Martin P Zeidler.   

Abstract

The JAK/STAT signal transduction pathway has traditionally been viewed as a cytokine-stimulated activator of gene expression consisting of a straightforward receptor/JAK kinase/STAT transcription factor cascade. Recent studies in Drosophila, have, however consistently identified a range of chromatin-remodelling factors as regulators of in vivo JAK/STAT signalling. Now, the detailed analysis of one of these, heterochromatin protein 1 (HP1), has provided an insight into an unexpected non-canonical in vivo role for STAT. In this model, unphosphorylated STATs associate with and maintain the stability of transcriptionally repressed heterochromatin--an effect countered by the recruitment of STAT to the canonical pathway. We examine the background of this new model and its implications for JAK/STAT pathway requirements in stem cell maintenance and cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840523     DOI: 10.1016/j.gde.2008.09.002

Source DB:  PubMed          Journal:  Curr Opin Genet Dev        ISSN: 0959-437X            Impact factor:   5.578


  18 in total

1.  Thymidine phosphorylase inhibits vascular smooth muscle cell proliferation via upregulation of STAT3.

Authors:  Hong Yue; Kuniyoshi Tanaka; Tatsuhiko Furukawa; Sadashiva S Karnik; Wei Li
Journal:  Biochim Biophys Acta       Date:  2012-06-02

Review 2.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

3.  Activation of the STAT6 transcription factor in Jurkat T-cells by the herpesvirus saimiri Tip protein.

Authors:  Yuri Kim; Eun-Kyung Kwon; Ju-Hong Jeon; Insuk So; In-Gyu Kim; Myung-Sik Choi; Ik-Sang Kim; Joong-Kook Choi; Jae Ung Jung; Nam-Hyuk Cho
Journal:  J Gen Virol       Date:  2011-10-19       Impact factor: 3.891

4.  Glypicans regulate JAK/STAT signaling and distribution of the Unpaired morphogen.

Authors:  Yoshiki Hayashi; Travis R Sexton; Katsufumi Dejima; Dustin W Perry; Masahiko Takemura; Satoru Kobayashi; Hiroshi Nakato; Douglas A Harrison
Journal:  Development       Date:  2012-11       Impact factor: 6.868

5.  Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis.

Authors:  Randall E Ryan; Bryan Martin; Liliana Mellor; Reed B Jacob; Ken Tawara; Owen M McDougal; Julia Thom Oxford; Cheryl L Jorcyk
Journal:  Cytokine       Date:  2015-01-23       Impact factor: 3.861

6.  Unphosphorylated STAT and heterochromatin protect genome stability.

Authors:  Shian-Jang Yan; Su Jun Lim; Song Shi; Pranabananda Dutta; Willis X Li
Journal:  FASEB J       Date:  2010-09-16       Impact factor: 5.191

7.  The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia.

Authors:  Dagmar Schinnerl; Klaus Fortschegger; Maximilian Kauer; João R M Marchante; Reinhard Kofler; Monique L Den Boer; Sabine Strehl
Journal:  Blood       Date:  2014-12-16       Impact factor: 22.113

Review 8.  Organogenesis and tumorigenesis: insight from the JAK/STAT pathway in the Drosophila eye.

Authors:  Ying-Hsuan Wang; Min-Lang Huang
Journal:  Dev Dyn       Date:  2010-10       Impact factor: 3.780

9.  Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth.

Authors:  Xiaoyu Hu; Pranabananda Dutta; Amy Tsurumi; Jinghong Li; Jingtong Wang; Hartmut Land; Willis X Li
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-03       Impact factor: 11.205

10.  Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer.

Authors:  Alicia E Woock; Jacqueline M Grible; Amy L Olex; J Chuck Harrell; Patricija Zot; Michael Idowu; Charles V Clevenger
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.